Projects funded by the ACRF
We provide capital grants for the establishment of capital works and facilities (including scientific equipment and other technologies), and national enterprises in support of all aspects of cancer research, including but not limited to cell and molecular biology, epidemiology, prevention and drug development.
The ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects with value over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
Assessment of applications
All applications are considered and assessed by the ACRF’s Medical Research Advisory Committee (MRAC), a group of highly distinguished research scientists who are appointed by the ACRF’s Board of Trustees. The procedures of the MRAC are similar to those employed by the National Health & Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants.
The MRAC’s recommendations for funding are reviewed and finalised by the Foundation’s Board of Trustees.
2017 Grant Applications
Applications for the 2017 Grant Round will be accepted from Monday, 3 April 2017 with the grant round closing on Friday, 23 June 2017.
Eligible persons and groups (as defined in the application guidelines) are invited to submit a single detailed written application.
ACRF’s Medical Research Advisory Committee (MRAC) will select from these applications a short-list, on the basis of eligibility and scientific merit, that will proceed to interview and, if deemed appropriate, a site visit.